相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deciphering the Systems Biology of mTOR Inhibition by Integrative Transcriptome Analysis
Sophie Domhan et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Everolimus-induced Pneumonitis after Drug-eluting Stent Implantation: A Case Report
Susumu Sakamoto et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Granuloma-forming Interstitial Pneumonia Occurring One Year after the Start of Everolimus Therapy
Yoshinobu Saito et al.
INTERNAL MEDICINE (2013)
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J. Bissler et al.
LANCET (2013)
Patterns of Interstitial Lung Disease During Everolimus Treatment in Patients with Metastatic Renal Cell Carcinoma
Ryuichi Mizuno et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Inhibition of Mammalian Target of Rapamycin Augments Lipopolysaccharide-Induced Lung Injury and Apoptosis
Jill A. Fielhaber et al.
JOURNAL OF IMMUNOLOGY (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The mTOR/AKT Inhibitor Temsirolimus Prevents Deep Infiltrating Endometriosis in Mice
Mahaut Leconte et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment
Amber L. Degryse et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Exogenous lipoid pneumonia. Clinical and radiological manifestations
Edson Marchiori et al.
RESPIRATORY MEDICINE (2011)
Pulmonary alveolar proteinosis
R. Borie et al.
EUROPEAN RESPIRATORY REVIEW (2011)
Rapamycin Regulates Bleomycin-Induced Lung Damage in SP-C-Deficient Mice
Satish K. Madala et al.
PULMONARY MEDICINE (2011)
ApoE-Deficient Mice on Cholate-Containing High-Fat Diet Reveal a Pathology Similar to Lung Sarcoidosis
Andriy O. Samokhin et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma
Dorothy A. White et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Amiodarone Review of Pulmonary Effects and Toxicity
Spyros A. Papiris et al.
DRUG SAFETY (2010)
Targeted PPARγ deficiency in alveolar macrophages disrupts surfactant catabolism
Anna D. Baker et al.
JOURNAL OF LIPID RESEARCH (2010)
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis.
Darcy A. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Methylnaltrexone Potentiates the Anti-Angiogenic Effects of mTOR Inhibitors
Patrick A. Singleton et al.
VASCULAR CELL (2010)
The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity
M. D. Saeemann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response
Anagha Malur et al.
JOURNAL OF IMMUNOLOGY (2009)
Everolimus Inhibits Monocyte/Macrophage Migration in Vitro and Their Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits
Roberta Baetta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
mTOR, cancer and transplantation
Edward K. Geissler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Bronchiolitis obliterans organizing pneumonia: Pathogenesis, clinical features, imaging and therapy review
Al-Ghanem Sara et al.
ANNALS OF THORACIC MEDICINE (2008)
In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function
Amelia Barilli et al.
CARDIOVASCULAR RESEARCH (2008)
Everolimus-related pulmonary toxicity in heart transplant recipients
Victor Exposito et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Loss of ABCG1 results in chronic pulmonary inflammation
Angel Baldan et al.
JOURNAL OF IMMUNOLOGY (2008)
Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Robert J. Motzer et al.
LANCET (2008)
Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome- a single-centre experience and review of the literature
Stefan M. Weiner et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Alveolar macrophage depletion is associated with increased surfactant pool sizes in adult rats
Amy Forbes et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Everolimus-induced rnTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy
Wim Martinet et al.
AUTOPHAGY (2007)
Selective clearance of macrophages in atherosclerotic plaques by autophagy
Stefan Verheye et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Four cases of sirolimus-associated interstitial pneumonitis: Identification of risk factors
C. Morath et al.
TRANSPLANTATION PROCEEDINGS (2007)
Surfactant protein A and surfactant protein D variation in pulmonary disease
Grith Lykke Sorensen et al.
IMMUNOBIOLOGY (2007)
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus
I. Duran et al.
EUROPEAN JOURNAL OF CANCER (2006)
Cryptogenic organising pneumonia
J. -F. Cordier
EUROPEAN RESPIRATORY JOURNAL (2006)
Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate
L Howard et al.
CHEST (2006)
Brief communication:: Sirolimus-associated pneumonitis:: 24 cases in renal transplant recipients
L Champion et al.
ANNALS OF INTERNAL MEDICINE (2006)
Patterns of pulmonary complications associated with sirolimus
Prashant N. Chhajed et al.
RESPIRATION (2006)
Pathogenesis and natural history of usual interstitial pneumonia - The whole story or the last chapter of a long novel
RM Strieter
CHEST (2005)
Inhibition of mammalian target of rapamycin potentiates thrombin-induced intercellular adhesion molecule-1 expression by accelerating and stabilizing NF-κB activation in endothelial cells
M Minhajuddin et al.
JOURNAL OF IMMUNOLOGY (2005)
Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras
M Wislez et al.
CANCER RESEARCH (2005)
Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts
LC Wu et al.
CANCER RESEARCH (2005)
Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer
CJ Bruns et al.
CLINICAL CANCER RESEARCH (2004)
Pulmonary alveolar proteinosis
BC Trapnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia
S Knapp et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages
AM Woltman et al.
BLOOD (2001)
Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema
RJ Kaner et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients
S Imokawa et al.
EUROPEAN RESPIRATORY JOURNAL (2000)
分享论文
